Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity ...

Eli Lilly said on Thursday the U.S. Food and Drug Administration has approved its treatment for a form of advanced breast ...

Eli Lilly ( LLY 1.32%) is now known for its weight loss drugs. Its stock has risen 150% since mid-2022 because of high demand for Mounjaro (tirzepatide approved to treat type 2 diabetes) and Zepbound ...

FILE - This undated photo provided by the U.S. Centers for Disease Control and Prevention (CDC) shows a blacklegged tick, also known as a deer tick, a carrier of Lyme disease. (CDC via AP, File) ...

Eli Lilly’s new GLP-1 drug and diversified R&D pipeline could drive healthcare sector inflows and deliver over 40% upside.

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. WASHINGTON — Lyme disease can cause serious harm, but so can bogus tests and ...

Eli Lilly And Company ((LLY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...

EYES, FOLLOWED BY A RASH. A COUPLE OF DAYS LATER. SO YOU MAY LOVE THE OUTDOORS AND WE ALL LOVE THE OUTDOORS, BUT IT’S THE SEASON OF TICKS AND THAT’S THE GIFT THAT KEEPS ON GIVING, CAUSING SOME HEALTH ...

Lyme disease can cause serious harm, but so can bogus tests and treatments. The complexity of diagnosing the tick-borne disease has given rise to an entire industry of unapproved tests and unproven ...